Royalty Pharma plc
$33.54B- Market cap
- $24.83B
- Debt
- +$9.33B
- Cash
- −$618.70M
Capital structure 73% equity / 27% debt · EV / Revenue 14.11x · EV / EBITDA 31.91x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RPRX · current priceP/E 35.94x
$63.98Latest market snapshot
Implied fair value · at AORT's multiple
$216.82238.9% above market
1.78 RPRX EPS (TTM)×121.81x AORT P/E=$216.82
Market $63.98Implied $216.82
AORT · current priceP/E 121.81x
$25.58Latest market snapshot
Implied fair value · at RPRX's multiple
$7.5570.5% below market
0.21 AORT EPS (TTM)×35.94x RPRX P/E=$7.55
Market $25.58Implied $7.55